Tanan Bejrananda
Papers
3
Total Citations
36
H-Index
3
About
Dr. Tanan Bejrananda is a leading urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for prostate and bladder cancers. His major contributions focus on optimizing patient outcomes through meticulous comparative studies. In a landmark 2023 study (24 citations), he demonstrated that nerve-sparing robot-assisted radical prostatectomy (RARP) significantly improves "pentafecta" outcomes—a composite of continence, potency, cancer control, negative margins, and no complications—compared to non-nerve-sparing approaches. This work provides crucial evidence for surgical decision-making. Dr. Bejrananda also conducted a pivotal 2025 systematic review and meta-analysis (8 citations) evaluating the cost-effectiveness of RARP versus open and laparoscopic prostatectomy, offering essential insights for healthcare policy in high-income countries. Additionally, his 2024 research (4 citations) confirmed the safety and efficacy of robot-assisted radical cystectomy with intracorporeal ileal conduit in older patients, challenging age-related surgical biases. Through rigorous, high-impact studies, Dr. Bejrananda continues to shape best practices in robotic urologic oncology, improving both clinical outcomes and healthcare economics.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3